Cylexin CY-1503: Began Phase II trial

Cytel Corp. (CYTL), San Diego Product: Cylexin CY-1503 small carbohydrate blocker of cell adhesion in inflammation Indication: Prevent reperfusion injury in heart attack patients undergoing angioplast...